Intriguingly, our findings suggest that only certain obesity-related outcomes, perhaps those more closely tied to metabolic disruptions such as insulin resistance and ectopic fat, are causally associated to SH3BP4 methylation, while others closely related, such as BMI, are not. The gene discussed is SH3BP4; the disease is Insulin resistance.